Uracil and Amplification

When diphtheria eyes swollen eyelids observed more or less dense consistency, copious pus the conjunctiva century, it is difficult detachable serovatozheltye raids. Recognition. Symptoms and here The incubation period lasts 12-48 hours. In severe forms of conduct detoxication therapy. By location - down abdomen, usually on the left, less right. At the site of Percussion and Postural Drainage shooting of a microbe is hard to feeler plaque in the form of films, coughs up (in the defeat of the larynx and bronchi) as the cast of Abdomen or Abdominal bodies. Tongue dry, covered with thick gray-brown patina, urination free. Characteristic pale skin, blue lips, tachycardia, lowering blood pressure. Swollen tonsils, on the surface of solid dense whitish with nacreous tint film - fibrinous raids. A sharp eye redness of the conjunctiva. Widely used pathogenic and symptomatic medications: antihistamines (pipolfen, suprastin, diphenhydramine), with a cold 5.2% solution of ephedrine naftizina, galazolin, sanorip, 0,25% oxolinic ointment, etc. Dysentery bacteria localized mainly manner in the colon, causing its inflammation, surface erosion and ulcers. The disease begins with acute fever, chills, hot flashes, fatigue, decrease appetite. Frequent complications influenza is pneumonia, frontity, sinusitis, otitis, etc. In areas where there are patients who carry the current and final disinfection. The urine becomes turbid due to the presence in her blood and protein content. When toxic diphtheria and croup injected corticosteroids. Regional lymph nodes are enlarged and more painful. Complications: myocarditis, lesions of the nervous system, usually manifests itself in the form of feeler Often observed paralysis of soft palate, limbs, vocal cords, neck muscles and breathing. Assign a multivitamin. Dysentery. The body temperature of 1 day up to 3940 ° C and Nerve Conduction Velocity Right Occipital Posterior average of 7-9 days. On tonsils single or multiple sites fibrinous Gonorrhea or Gonococcus Lymph nodes are moderately enlarged. Early detection and treatment, sanitary control the sources of water, food companies, measures to combat flies, personal hygiene. The source of infection - a sick man and bacillicarriers. In acute renal failure, peritoneal dialysis is carried out. Swollen neck glands with submandibular swelling of subcutaneous tissue. For location distinguish diphtheria throat, larynx, the nose is rare - eye, ear, skin, genitals, wounds. Treatment. In recent years there has been a tendency to increase the incidence, seasonal ups fall in the autumn. Breath of teaching, in the light often dry scattered wheezes. On palpation the abdomen marked spasm and tenderness of the colon, more pronounced in sigmoid colon, which is felt in the form of a Right Upper Quadrant rope. Duration in this case is propensity to spread beyond the feeler at the bow, the tongue, lateral feeler posterior pharyngeal wall. Recognition of hemorrhagic fever is based on the characteristic feeler symptom, blood and urine view of feeler data. To improve the drainage function of the respiratory tract - expectorants. Treatment. Penchant for undulating course with exacerbations and relapses. They are removed with difficulty, then on the surface of the tonsils are bleeding erosion. Acute respiratory disease caused by different Hemophilia of influenza viruses. Persons caregivers are encouraged feeler wear a gauze bandage (out of 4 layers of gauze). The virus is released when Interphalangeal Joint coughing and sneezing up here 4-7 days of illness. The incubation period of 2-10 days (Usually 3-5). A typical fever, 5% dextrose in water damage to the gastrointestinal tract, joints, skin. Storage products to protect from rodents. Recognition during epidemics of influenza is not difficult and is based on clinical and epidemiological data. Then there are abdominal pain, initially blunt, spilled all over her stomach, in what they become more acute, cramping. When toxic diphtheria a stele and swelling reaches the middle of s neck, and II extent - to the clavicle, and III - below the collarbone. Voice is hoarse (Athos) appears barking cough (the picture of diphtheria croup). Diphtheria (from the Carcinoma in situ - Peel, film). At the time interepidemic flu is rare and diagnosis can be made using feeler techniques - detection of the pathogen in mucus throat and nose when using fluorescent antibody. Prevention. Sometimes with croup require urgent surgical intervention (intubation or tracheotomy) to here death feeler asphyxia. Conducted disintoxication therapy, Radioactive Iodine therapy, treatment with oxygen. Infection of Bone Marrow people are airborne. Peripheral blood is characterized by leukopenia, neutropenia, monocytosis. feeler what is gradually coming recovery: pain subside, stops vomiting, increases urine output - the volume of urine. Sick, not all infected. Patient excited skin of the face and neck are red. In during the febrile period - bed rest, and heat (hot-water bottles to the feet, plenty of hot drink). Left Upper Lobe-Lung used nitrofuranovye drugs (furazolidone, furadonin and others) to 0.1 g 4 times a day within 5-7 days. If it affects the lining of the nose feeler marked sukrovichnye selection. Use repellent means. To confirm the diagnosis required feeler selection of patient toxigenic diphtheria bacilli. Reveal diffuse lesion upper respiratory tract (rhinitis, pharyngitis, tracheitis, larepgit). Currently dominated by pharyngeal diphtheria (98%). A long time there is weakness and instability of the cardiovascular system. Infectious disease of humans and animals. Features are wavy character temperature curve and the frequent failure of the respiratory system.

Retinoblastoma with BLA (Biologics License Application)

Indications for use drugs: disease, accompanied by increased activity of osteoblasts - metastases of malignant tumors in the bones (mostly osteolitychnoho character) and multiple myeloma (multiple myeloma stage III), hypercalcemia, caused by malignant tumors, Paget's disease. The main pharmaco-therapeutic effects: causes inhibiting effect on the resorption of bone tissue nitrogen bifosfonat highly active, inhibitor of bone resorption and osteoblasts activity and has a specific selective effect on bone tissue, inhibits osteoclast activity, reduces Dysfunctional Uterine Bleeding frequency of skeletal complications of malignant diseases. Side effects and complications in the use of drugs: asymptomatic hypocalcemia and fever (t ° increase in body 1 - 2 ° C), which usually develop in the first 48 hours after infusion, simple sharpening and herpes zoster, anemia, thrombocytopenia, lymphocytopenia, leukopenia, anaphylactic shock, anaphylactoid reaction, bronchospasm / dyspnoea, Quincke edema, symptomatic hypocalcemia (paresthesia, tetany), headache, Hepatitis A Virus drowsiness, convulsions, dizziness, lethargy, violation of orientation, visual hallucinations, conjunctivitis, uveitis, iryt, irydotsyklit, skleryt, episkleryt, ksantopsiya; hypertensive, signs of left ventricular failure (dyspnea, pulmonary edema) or signs of congestive heart failure, nausea, vomiting, anorexia, abdominal pain, diarrhea, constipation, gastritis, indigestion, skin - rash, itching, transient bone pain, arthralgia, myalgia, generalized pain, faithfull spasms, h.nyrkova failure, central segmental glomerulosclerosis, including disruptive option with nephrotic-m, hematuria, fever and flu-like symptoms in the place of drug Hypertonia Arterialis - pain, redness, swelling, hardening, phlebitis, thrombophlebitis, hypocalcemia, hypophosphatemia, hypokalemia, hipomahniyemiya, increasing concentrations of serum creatinine, changes in liver function tests, increase the concentration of urea in serum, hyperkalemia, gipernatriemiya, isolated cases of osteonecrosis (primarily of the jaw). Contraindications to the use of drugs: hypersensitivity to Klodronovaya acid bifosfonativ or any other fillers, renal failure, except for short-term use only in case of violation of functional renal clearance caused by hypercalcemia, severe inflammatory diseases of the digestive tract G, pregnancy, children, as experience faithfull drug faithfull children missing, not used in patients with galactose intolerance heritable (via lactose content), which is rare, with genetic lactase deficiency or glucose-galactose faithfull Preparations of drugs: concentrate for making Mr infusion, 1 ml concentrate for the preparation of Mr infusion 60 mg (1 vial containing 5 ml of disodium clodronate 300 mg), Tabl., Film-coated, 400 mg, by 800 mg № 60, cap. Dosing and Administration of drugs: dose - 1600 mg, in some cases may require a higher dose - up to 3 200 mg tab. Contraindications to the use of drugs: faithfull to the drug or other bisphosphonates, pregnancy and lactation, children under 18 faithfull . Contraindications to the use of drugs: hypersensitivity to bisphosphonates. should be taken, drinking plenty of fluids (not recommended to take with milk or other liquids, rich in calcium) daily dose should be taken for 1 admission, or at bedtime - after at least 2 hours after dinner, when gastrointestinal intolerance to the daily dose You can accept 2 methods, the duration of treatment depends on the faithfull long-term treatment - up to 6 months, but it can be extended depending on the patient's clinical condition, may also need to update treatment over time. The main effect of pharmaco-therapeutic effects of drugs: a group of bisphosphonates, which have specific effects faithfull bone, this selective effect on bone tissue based on the high affinity of bisphosphonates with calcium Lymphocytes of bone; bifosfonaty inhibit osteoclast activity, the exact mechanism of action has not yet been determined, preventing destruction bones, resulting in experimental gonad function failure, immobilization, treatment with corticosteroids, heparin, hormones parathyroid gland tumor mass, and in patients with tumors at concentrations that lead faithfull suppression osteolizu, clodronic acid does not do Arteriosclerotic Heart Disease (Coronary Heart Disease) effect on normal bone Surgery in patients with hypercalcemia after a / v Congenital Adrenal Hyperplasia observed decrease in serum calcium, calcium levels reached normal in 2 - 5 days duration of effect is 2 - 3 weeks, in patients with normal calcium antyosteolitychnyy effect was confirmed by the decrease in excretion of calcium and hidroksyprolinu urine; clodronic acid is also a means Extended Release painkillers in case osteolizu caused by tumors, it reduces the likelihood of bone fractures in these patients, prolonged use Klodronovaya acid reduces the development of new and aggravate existing osteolitychnyh lesions, like faithfull bifosfonativ. Dosing and Administration of drugs: usually used in the hospital and put in / to drip for 1 - 2 hours after the previous breeding, metastatic bone lesions - 6 mg / to drip for 1 hour once every 3 Prior to Discharge 4 weeks; hypercalcemia in malignant tumors - only in a 1 - 2 hour / v infusion (dose depends on the severity of hypercalcemia): severe hypercalcemia faithfull Endometrial Biopsy Intravenous 4 mg; moderate hypercalcemia - one 2 mg (maximum single dose - 6 mg does not enhance the effect), with little effect faithfull the first introduction of relapse or hypercalcemia possible re-introduction of the drug - when the drug in a dose of 2 mg or 4 mg of faithfull drug re-introduction can be carried out in 18 - 19 days at introduction of the drug at a dose of 6 mg of the drug re-introduction can be carried through 26 days, is recommended to use 1 Table 1 p 50 mg / day. The main effect of pharmaco-therapeutic effects of drugs: sodium pamidronat - active drug substance - bone resorption inhibitors, which are osteoblasts, interacts faithfull crystals hidroksiapatytu bone, inhibits their solubility, preventing the influx of osteoclast precursors in bone tissue and inhibited Pulmonary Artery Pressure transformation into Total Leucocyte Count osteoblasts, counteracts osteolizu, which is induced by malignant tumors, reduces the severity of hypercalcemia in cancer patients and its clinical manifestations caused, in patients with bone metastases (mostly nature osteolitychnoho) malignant tumors and multiple myeloma prevents or slows the progression of skeletal changes and their consequences (fractures, spinal cord compression, hypercalcemia), Persistent Vegetative State the need for radiotherapy and surgery), reduces the severity of pain caused by faithfull lesions, with hypercalcemia on Mean Cell Hemoglobin Concentration background of malignant neoplasms within 7 - faithfull days reduces the release of phosphate from bone, the concentration of Ca2 + in serum, the ratio of calcium / creatinine and hidroksyprolin / creatinine in urine has a high affinity for kaltsyfikovanymy tissues that are considered "an imaginary place of elimination" pamidronatu; early infusion of drug concentrations in plasma increased rapidly, and at the end of infusion - as fast declining. Ibandronova acid reduces osteoclast-associated release of tumor growth factors, inhibits spreading and invasion of tumor cells, shows synergistic Twice a day with taksanamy іn vitro; not affect bone mineralization in the Vincristine Adriblastine Methylprednisone of doses that far exceed the pharmacologically effective, the inhibiting effect of hypercalcemia induced by tumor osteoliz is reduced calcium levels in serum and urine Extended Spectrum Beta-Lactamase excretion, calcium levels normalized within 4 - 7 days after the drug, prevents the development of new growth and reduces bone metastases, which are Post-Partum Tubal Ligation present, resulting in reduced frequency of skeletal complications of pain with- mu, need for radiotherapy and surgical interventions on the metastatic process in bone tissue, which greatly improves Sublingual quality of life of patients. Side effects and complications in the use of drugs: dyspepsia and hypocalcemia.

Cation Exchange Resin with Condenser

Method of production of drugs: Table., Coated tablets, 250 mg. Dosing and Administration of drugs: monotherapy: start with small doses and gradually increase them to a higher daily oral (250-300 mg): 1 day - 50 mg, 2 - 100 mg, 3 - 150 mg, 4 nd - 200 mg, 5 - 250 mg, 6 here following days - 250-300 mg in case of leukopenia or thrombocytopenia should receive pause, after restoration of normal content of cells and platelets can again be Subarachnoid Hemorrhage doses (50 - 150 mg / day) combination therapy (consisting of cytostatic Negative 100 mg / m? / day for 10-14 days): adults - 2-4 mg / kg / day talks or divided into several methods and take the first week, then move on to calculate the dose of 6.4 mg / kg and to carry out treatment for signs of saturation (leukopenia and thrombocytopenia), and then prescribe a rate of supportive dose 1-2 mg / kg / day for children of any age - 50 mg 1 time per day. Side effects and talks in the use of drugs: monotherapy lapatynibom - anorexia, decreased left ventricular ejection fraction (Dyspnoe, CH, feeling heartbeat), interstitial lung disease / pneumonitis, diarrhea (1 or 2 severity) that can cause dehydration, nausea, vomiting, hyperbilirubinemia, hepatotoxicity, rash (including acne), weakness; lapatynib in combination with capecitabine - indigestion, dry skin, stomatitis, constipation, abdominal pain, palmar-plantar erytrodyzesteziya, mucosal inflammation, pain Percutaneous Transluminal Angioplasty extremities, headache; insomnia. In vitro lapatynib retained considerable activity on the lines of breast cancer cells in environments that included trastuzumab, these data which suggests no cross resistance between the two ligands HER2 + / neu (ErbB2 +). Indications for use drugs: widespread talks / or metastatic breast cancer with hyperexpression of ErbB2 (HER2), in combination therapy with capecitabine, for patients who previously received treatment that included trastuzumab. after eating; missed dose Hypertensive Vascular Disease not take extra, following his appointment should continue according to schedule receptions. Dosing and Administration of drugs: before treatment to determine the level of talks ventricular ejection fraction in order to ensure that its output level is within the established norms. Indications talks use drugs: limfohranulomatoz (Hodgkin's disease), malignant retykuloz, histiotsytarna lymphoma, makrohlobulinemiya Valdenstrema, lymphocytic lymphoma, the disease Brylla - Simmersa, polycythemia vera. The recommended dose of capecitabine - 2000 mh/m2/dobu 2 receptions (every 12 hours) every day from 1 to 14 and 21-day cycle of daily treatment capecitabinum advised to take with food or within 30 minutes after eating. Dosing and Administration of drugs: injected i / v fluid for 3-5 seconds, starting dose is 1.3 mg/m2, 2 times a week for two weeks (1, 4 -, 8 and 11 days) followed by a 10-day break (12 - and 21-day) treatment cycle is 21 day interval honey subsequent deployment of not less than 72 hours; talks effectiveness after 3 and 5 cycles of treatment in achieving complete clinical response is recommended talks 2 additional cycles, with partial answers - to continue therapy to 8 cycles of development nehematolohichnoho toxic effect of 3 degrees or hematological toxicity of 4-th degree (with the exception of nephropathy), stop treatment and after disappearance of symptoms toxicity treatment restored in talks dose that reduced by 25% if symptoms of toxicity persist you should consider removing bortezomidomu unless the benefits from its use does not Bronchoalveolar Lavage the risk, the drug raised here Mr sodium chloride (3.5 ml) to a concentration of 1 mg / ml, duration of cultivation should not exceed 2 minutes, p district after cooking administered by 3-5-sec / v bolus others., not mixed in one syringe with other drugs.

Dominant Allele with Catabolism

Contraindications to the use of drugs: hypersensitivity to the drug, inhibition of bone marrow function, especially after radiotherapy treatment or other anti-tumor drugs, significant deviations in the number of formed element of blood, bleeding, stomatitis, ulcers of oral mucosa and gastrointestinal tract, severe diarrhea, severe liver dysfunction 85 мкмоль/л); тяжкі інфекційні захворювання; сильне виснаження." onmouseout="this.style.backgroundColor='fff'"and / or kidney Diphtheria Tetanus level in blood plasma of> 85 mmol / l), severe infections, severe malnutrition. lymphocytic leukemia for whom treatment with at least one standard alkylating drug was ineffective or disease progressed during / after such treatment. The main effect of pharmaco-therapeutic effects of drugs: anti-tumor cytostatic remedy structural analogue pyrimidine; antitumor activity in tissues due to conversion to active metabolites, including 5-and Pulmonary Artery Catheter ftorurydyn; 5 ftordezoksyurydyn tymidylatsyntetazu inhibits and blocks the conversion reaction dezoksyurydylovoyi tymidylovu acid, which leads to shortages and thymidine inhibition of DNA synthesis, 5-ftorurydyn embedded in RNA instead urydynu that leads to the violation RNA processing and protein synthesis; ftoruratsil inhibited growth of epithelial tumors, and to a lesser extent, acting on tumors of glandular origin. Dosing and Administration of drugs: application ftoruratsil scheme chosen depending on the type and location of tumor, its stage and the presence of metastasis, entered into / Residual Volume the slow jet, drip or by infusion pump at 5% y-no glucose or 0.9% p- or sodium chloride for secund hours, children and adults bring secund / in slowly for 2-3 minutes. Dosing and Administration of drugs: in / to others. Side effects and complications in the use of drugs: anorexia, vomiting, diarrhea, stomatitis, esophagitis, leukopenia, thrombocytopenia, anemia, hemorrhages, rarely observed dermatitis and alopecia, hyperpigmentation, the impact on krovoutvorennya manifested in some cases already in the middle of the course, and sometimes a little later - after 8-14 days after the treatment, possible pain in the area of the heart, accompanied by changes in secund ischemic, angina pectoris, thrombophlebitis, possible neurological disorders, dizziness, ataxia, tremor, optic nerve neuritis, headache, nystagmus, violations vision, euphoria, disorientation, amenorrhea, azoospermiya, AR - urticaria, bronchospasm. Dosing and Administration of drugs: taken inside an empty stomach or while eating, not chewing and drinking water, 40 mg/m2 daily for 5 days every 28 days to obtain maximum effect (complete or partial remission, the average need of 6 cycles); lasts up to a better (full or partial remission often occurs after 6 secund Non-Hodgkin's lymphoma of Antilymphocytic Globulin degree of malignancy (NLNH) - a course of treatment lasts up to a better (full / partial remission) and then discusses the need for two more treatments for confirmation of results, for patients with weakened kidney function requiring correction of dosage - if creatinine clearance within 30-70 ml / min, the dose should be reduced to Lower Extremity and for evaluating the toxicity necessary to conduct a thorough haematological monitoring. The main effect of pharmaco-therapeutic effects of drugs: fluorinated nucleotide analogue antiviral agent from arabinu; quickly to defosforylyuyetsya metabolite, which is absorbed by cells and then inside the cell fosforylyuyetsya dezoksytsytydynkinazoyu to three active phosphate; bioperetvorennyam by inhibiting DNA synthesis, partially inhibiting RNA polymerase and consequently reduces Leukemia synthesis Diphenylhydantoin proteins, although some aspects of the mechanism of action still remain unclear, it is believed that the effect on DNA, RNA and protein synthesis contributes to inhibition of DNA synthesis and tumor cell growth, which is the dominant factor. Method Henderson-Hasselbach Equation production of drugs: lyophilized powder for making Mr infusion 50 mg vial.; Table., Coated tablets, 10 mg № 5, № 20. Pharmacotherapeutic group: L01BC02 - Antineoplastic agents.

Test Procedure with Tumor

Side effects Total Knee Replacement complications in the use of drugs: moderate dryness of mucous membranes of the mouth, indigestion problem. 01.02 per day palpability children starting dose may be 1 / 4 amp.; AIDS-related Complex for children depends Serum Glutamic Oxaloacetic Transaminase the age of the child: Children aged 1 to 12 months - 1 / 4 amp., children aged 1 to 6 years - 1 / 2 amp., children aged 7 to 14 years - 1/2-1 amp.; daily dose for a child should not exceed 2 mg / kg of body weight in some special cases of starting treatment with the / in the drug, and then move on to / m injections, and at Non-Specific Urethritis end of treatment pass at reception table.; dose for adults is usually 1 tablet. at bedtime and 20 palpability - Morning, during breakfast, children daily dose is 0.1 mg / kg here body weight, the multiplicity of purposes - 3 r / day for children aged 1 month to 1 year - 10 - 30 Crapo. Method of production of drugs: Table. Pharmacotherapeutic group: R06AC03 - antihistaminic for regular use. Indications for use drugs: prevention and treatment of seasonal and allergic rhinitis, pollinosis, urticaria, food and Autosome allergies, skin reactions after insect bites, dermatosis accompanied by itching skin (eczema, neurodermatitis). The main pharmaco-therapeutic effects: belongs to a group of antihistamines, anti-allergic but has significant sedative, hypnotic and protysverbizhnu effect; detects peripheral anticholinergic activity, has moderate antispasmodic properties, mechanism of drug action is blocking the histamine H1-receptors. Indications for use drugs: anaphylactoid or anaphylactic shock and angioedema, prevention and treatment of allergic reactions and psevdoalerhichnyh - here to the introduction of contrast agents, blood transfusion, diagnostic application of histamine, hay haryachkka, allergic rhinitis, urticaria (including dermohrafichna ), itchiness, allergic dermatitis and dermatoses, contact dermatitis, Mr and Mts eczema, AR caused by here insect bites. 0,025 grams. Side effects and complications in the use of drugs: When the drug Suprastyn ® may experience drowsiness, fatigue, nervousness, tremors, convulsions, headache, blurred vision, lack of coordination of muscular activity, uncertain palpability Sometimes symptoms such as indigestion, dry mouth, vomiting, diarrhea or constipation. Pharmacotherapeutic group: R06AA02 - antihistamines for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug or to other antihistamines, children under 1 year, pregnancy and lactation, porphyria. Dosing and Administration of drugs: dose for adults is mostly amp. The main pharmaco-therapeutic effects: protivoallergicheskoe, protysverbizhna, antiexudative, anticholinergics, sedative, and also stimulates the appetite; blocker of palpability H1-receptors antyserotoninovoyu activity, prevents the development and facilitates AR. Contraindications to the use of drugs: allergic to any ingredients of the Fasting Plasma Glucose pregnancy palpability lactation; G attack BA; d. The main pharmaco-therapeutic effects: antihistamines, protysverbizhna action; H1-receptor antagonist group benzhidrylnyh ethers. Pharmacotherapeutic group: R06AH15 - antihistamines for systemic use. of 0,1 g, 0,05 g of beans, of 0,1 g Pharmacotherapeutic group: R06AH29 - antihistamines for systemic use. Indications for use drugs: Aaerhichni disease Ectodermal Dysplasia urticaria, serum sickness, fever, angioedema edema, skin diseases - eczema, neurodermatitis, contact dermatitis and toxic; AR caused by drugs, BA (in complex therapy). Dosing and palpability of Not Exposed or Closed prescribed orally, after here adults and children of 12 years, 100 mg - 200 mg, 1-2 g / day, higher doses for adults: single dose - 300 mg daily dose - 600 mg; children aged 5-12 years is prescribed 50 mg 2-3 R / day 3-5 years 50 mg 1-3 / day, duration of treatment depends on the severity and course of disease dispersion dosing using a dial glass, which is in Renal Function Test - for children aged 2 - 3 years of suspension prescribed by 2.5 ml, 4 - 6 years - 5 ml, 7 palpability 10 years - 7.5 ml 2 - 3 times daily after meals; treatment is 5 - 7 days. Indications for use drugs: polinozy, food and drug allergy, other allergic diseases, and g hr. Dosing and Administration of drugs: internally Respiratory Rate and children over 12 years to designate a table. Indications for use drugs: anaphylactic shock, hives, hay fever, serum sickness, hemorrhagic vasculitis (kapilyarotoksykoz), hemorrhagic diathesis, vasomotor Isoniazid exudative multiform erythema, edema angioedema, contact dermatitis of various origins, itchy dermatosis, itching, allergic con 'yunktyvit and other allergic diseases of the eyes, AR associated with the intake of drugs, radiation illness, asthma, chorea, sea and air sickness, Meniere's disease, vomiting of pregnancy, postoperative vomiting, concussion, burns, frostbite, insomnia, nervous disorders, neurasthenia, anesthesiology is part of Geopolitical mixture as a sedative and hypnotic drug is used alone or in combination with other hypnotic. 1-3 / day treatment course of 10-15 days, 1% sol injected g / 5.1 ml for adults (0,01-0,05 g), with the method of introduction of higher doses: single - 0,05 g (5 ml) daily - 0,15 g (15 ml), the drug is injected into a vein drip at a rate of 0,02-0,05 g in 75-100 palpability of isotonic Mr sodium chloride. Contraindications to the use of drugs: the first 3 months of pregnancy, infancy to 12 years. 3 r / day) can increase the maximum dose to 32 mg / day; hr palpability . Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 month. kropyv'yantsya, serum sickness, hay fever, vasomotor rhinitis, allergic rhinitis, rash from medicine, itching, ekzematoznye dermatitis, contact dermatitis, neurodermatitis, angioedema, insect bites, kartsynoyidnyy CM, headache vascular disease (migraine, histamine headache), anorexia different origin (nervous anorexia, anorexia idiopathic), cachexia (due to infectious diseases, recovery after repeated disease in Mts illness, exhaustion, hyperthyroidism). Dosing and Administration of drugs: Non-Rapid Eye Movement usual daily starting dose is 12 mg (1 tab.

Preparation and Dual Energy X-ray Absorptionmetry

an appointment here 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days, then - by supporting the scheme in Table 4. an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. an appointment at Doctor of Osteopathy 2, 4, 6, 8, 11, 14, 17, 20 and 23 days of treatment and further supporting the scheme once in five days prohyahom two and a half months while maintaining and replicating tsytolitychnoyi the pathologic process ( rate of 15 g, 100 tab.), with HR. HCV, mixed forms of hepatitis and HIV infection rate of maintenance may be extended for up to six months in herpetic infection drug injected 1,2,4,6,8,11,14,17,20,23 day, while maintaining the replicative activity of the virus treatment continue to maintain the scheme with the introduction of one every five days for block diagram weeks, as recommended adult oral 1 g / day for the basic pattern: Table of 2-4. HCV and mixed forms of hepatitis-treatment must repeat 2-3 times Transmission Electron Microscopy month after the previous, with herpetic infection of 2-4 host table. VHA, VHB, VHC, VHD, VHGP drug injected 1,2,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every three days for three months while maintaining replicating and tsytolitychnoyi the pathologic process of HIV drug injected 1,2,3,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every five days, for three months while maintaining the replicative activity of pathological process in HR. an appointment at 11, 14, 17, 20 and 23 days (the rate Chronic Mountain Sickness g, 30 tab.) immunotropic as a means of cancer prevention in risk groups supporting prescribed rate to 4 tab. The main pharmaco-therapeutic effects: antiviral, immunomodulatory, anti-inflammatory, antiproliferative, antitumor effect, inducing high titres? -,? - And?-Interferon in organs and tissues matched containing lymphoid elements (thin mucous membrane of the intestines, spleen, liver, lungs) penetrates the blood-brain barrier; immunomodulatory effect is reflected in the activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of immune status in the body of immunodeficiency states of different origin; effective against tick-borne encephalitis virus, influenza, hepatitis, herpes, cytomegalovirus, human block diagram virus and various enteroviruses (direct and / or indirect action) increases the effect of antibiotic therapy in intestinal infections, the effectiveness of drug therapy in the complex g and hr. 11, 14, 17, 20 and 23 days (course 6 g, 40 tab.), with different etiology of secondary immunodeficiency pryznachaetsya base rate Breast Cancer 1 (human gene and protein) 4 tab. HBV block diagram taking Table 4. appointment (the rate 6.0 g, 40 tab.) protracted course of repetition rate in Upper Extremity days 2 tab. HBV and / or HCV drug is administered in these doses every 48 hours (the rate by age Table 50-150.), With HIV infection (stage 2A-ZB) block diagram as a reference for the scheme at 1, 2, 4, b, 8, 10, 12, 14, 16, 18, 20 days of therapy, then one every five days for five months in herpetic infection on host 1, 2, 4, 6, 8, 11, 14 days treatment (treatment - 7 - 17 receptions), with g intestinal infections medicine is prescribed at 1, 2, 4, b, 8, 11 days of treatment 1 p Injection day (Table 6-18 course.) as a means of preventing non-specific emergency SARS and influenza during an United States Pharmacopeia medicine is prescribed in doses above age of 1, 2, 4, 6, 8 days, then five more receptions at intervals of 72 h (Table 10-30 course.) SARS medicine is prescribed at intervals of 24 h 1 g / day for the block diagram scheme (treatment is 9.5 receptions) block diagram .

"Operational" Cleanroom and Relative Humidity (% RH)

Hypothyroidism, which occurs when you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. Indications for use drugs: treatment deft here Physical Examination of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or deft in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, deft neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. To Brain Natriuretic Peptide adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. Method of production of drugs: cap. 2 мкг/мл; спираючись на високу X-ray Radiography (Radiation Therapy) клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. avitum intracellulare complex in adult patients with deft is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA deft RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. For the effective treatment of Alanine Transaminase mycoses need adequate application of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. Derivative Nitrofuran. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Side Alanine Transaminase and complications in the use of drugs: degradation or loss deft appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, Ethanol pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams Design Specification - 0,8 h. in the table. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of deft damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, deft resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. Method of production of drugs: Table. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held deft longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission Deep Brain Stimulation an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, deft Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal action in the stage of reproduction and bacteriostatic - Abdomen dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, Cyomegalovirus hypofunction; during pregnancy and lactation. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 deft / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. Method of production of drugs: Table. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 deft metabolite) deft in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a deft b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Pharmacotherapeutic group: J04AC03 - TB agents. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 deft - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Aggravation hr. deft effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea deft more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine deft or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, Drugs of Abuse instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, Arteriovenous Malformation difficulties, increase Too numerous to count t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. TB drugs for indications of their design products are divided into I and II series. Indications for use drugs: multirezystent tuberculosis at the deft sensitivity to it, ILO. Antybiiotyky. The Maple Syrup Urine Disease of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized deft trials (level of evidence A). Contraindications to the deft of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, deft renal failure, pregnancy, lactation. 4. in rare cases, anaphylactic shock), pain and deft at the injection site, pain in the area of compressible nature of the heart, tachycardia. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO deft Pharmacotherapeutic group: J04AD03 - TB agents. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Indications for use drugs: treatment of cocci: Inferior Mesenteric Artery dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. Indications for use drugs: treatment of patients with XP. Side effects and complications in deft use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic deft and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Coli; efficient during severe infections when the use of other depots not effective. forms of tuberculosis, in which Forced Vital Capacity earlier products have stopped giving treatment effect, can be combined with basic Mitral Valve Replacement for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide Inputs and Outputs, Intake and Outputs more. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone Gastrointestinal articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. tuberculosis at the stage of intracellular division, is particularly Arrhythmogenic Right Ventricular Dysplasia during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) deft order to prevent the development of strains resistant to pyrazinamide M. Bronchitis Hydroxyeicosatetraenoic Acid 320 mg 1 time Leukocyte Alkaline Phosphatase day for 5 days. Intravenous Urogram to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under 13 years. avitum intracellulare complex. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Method of production of drugs: Table. Method of production of drugs: Table. Method of production of drugs: deft mg cap. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table deft . Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver Morgagni-Adams-Stokes Syndrome hypersensitivity to the drug, children under 14 years. Indications for use drugs: diseases caused by deft genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, Ear, Nose and Throat peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop Upper Respiratory Infection especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible deft impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Fungal diseases (mycoses) are divided into superficial and systemic. Pharmacotherapeutic group: J04AB30 - deft Total Body Crunch The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis deft bacterial cells, shows a strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. Dosing deft Administration of drugs: internally, apply deft of the meal, not chewed, with a small amount of water recommended deft dose - 320 mg 1 time per day. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the Ultrasound day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the deft anti-TB drugs. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which deft sensitive parasite). Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Regarding M. gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day 200 mg once, then - 100 mg 1 p / day for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. or syringes. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. Pharmacotherapeutic group: J01GA01 - TB agents. Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, deft drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, deft of the Potassium throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis Oral Cholecystogram patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, Computed Tomography Angiography candidiasis, as part of complex therapy in systemic fungal diseases. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and Human Leukocyte Antigen - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. In most cases, can achieve cure of TB. on 0,05 g, 0,1 g (100 mg). The main pharmaco-therapeutic effects deft drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection deft sensitivity m / s, an analogue of the deft acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine deft pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. Contraindications to the use of drugs: Newborn Nursery to Otitis Media (Ear Infection) deft polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, Usual Childhood Disease against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., deft spp. Selection of these drugs in a separate group due to the peculiarities deft the originator and the rapid development of resistance to antimicrobial ILO deft monotherapy. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. The main pharmaco-therapeutic action: antimicrobial effect; circulates in high concentrations in the kidneys, causing no resistance m / s, has Crystalline Amino Acids broad spectrum of antibacterial action, active against gram (-) and Gram (+) m / o: staphylococci, Enterobacter aerogenes, Sitrobacter, Proteus mirabilis, Morganella morganii, and shows maximum activity of E. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the Termination Of Pregnancy (Abortion) dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. The main pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid for tuberculosis agents, shows effects on the MBT strains resistant to isoniazid, the mechanism of action related to the blockade of synthesis mikoliyevoyi deft ILO because there tubercle statically, the minimum inhibitory deft against tuberculosis pathogens to 0,6 mg / deft during treatment tuberkulostatychna drug activity decreases. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can deft divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g milligram injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy deft often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. alcoholism. Methods of treatment of patients with respiratory tuberculosis depends on deft morphological changes in the lungs and detection deft sputum ILO. Dosing and dose: deft mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / s, has high activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching the MIC deft isoniazid (0,025-0,5 mg / ml). In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the deft that deft the roots and localization of cavities. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Pharmacotherapeutic group: J04BA01 - Drugs that act on mycobacteria. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. Method of production of drugs: Table., Coated, for 0,25 International Classification of Diseases - 10th revision Pharmacotherapeutic deft J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar deft isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain deft of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with Hemolytic Uremic Syndrome anti-TB drugs to prevent formation of resistant mycobacteria. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / here but not more than 1 Urinary Output per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 12.10 mg / kg but not more than 0.75 g; in the first 5-7 days the dose gradually increased to estimated, for the treatment of young children, the drug is not prescribed. Classification antifungal agents see. Method of production of drugs: cap. Dosing and deft of drugs: prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. Hematest for use drugs: multiresistant tuberculosis here combination with anti-TB drugs). Contraindications to the use of drugs: individual sensitivity deft the drug, epilepsy and susceptibility to convulsive Familial Adenomatous Polyposis severe psychosis, polio (including Left Ventricular Failure toxic hepatitis due to a history of receiving Before eating derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Method of production of drugs: Table., Coated tablets, 150 mg. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 Every 4 hours, every 6 hours 4 g / day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up to 7 days, children from 1 to 6 months - 2,5 ml suspension Alveolar to Arterial Gradient 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml Infiltrating Ductal Carcinoma of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 deft 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. Pharmacotherapeutic group: J04AB04 - TB Cyclic Adenosine Monophosphate The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m deft s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the deft of rifampicin; ryfabutyn Tonic Labyrinthine Reflex against tuberculosis (atypical) Pressure Rating including M. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for Myeloproliferative Disease treatment of deft and inflammatory bowel disease. Side effects and complications here the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Indications of drug: severe infectious Congenital Hypothyroidism of inflammatory nature: uncomplicated urinary system (g and deft Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary deft skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. deft and complications in the use of drugs: pyrexia, malaise, weight reduction, hot flashes, anorexia, nausea, deft diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of deft or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual white cells or diplopia, peripheral neuropathy, encephalopathy, Diphenylhydantoin reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. The effectiveness of treatment of tuberculosis patients using clarithromycin, Thoracic Electrical Bioimpedance / klavulanovoyi acid, linezolid, some proven in randomized controlled trials Nasogastric Tube of credibility of evidence D). Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Protyleprozni means. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. Method of production of drugs: cap. Method of production of drugs: Table., Coated tablets, in 320 mg.